Biogen

Biogen is a biotechnology company that develops medicines for hard-to-treat diseases, with a long track record in neurology and programs in immunology and rare diseases. The company describes its approach as applying deep knowledge of human biology across different treatment types to pursue first-in-class therapies, taking bold scientific risks balanced against return on investment. Its best-known medicines treat multiple sclerosis and spinal muscular atrophy.

Founded in 1978, Biogen says it has created medicines for hard-to-treat diseases for decades, with scientific curiosity at the core of its legacy. Its website features patient stories from people living with diseases such as paroxysmal nocturnal hemoglobinuria and cutaneous lupus erythematosus. The company’s culture statement centers on caring deeply, achieving excellence and changing lives for the people it serves.

What to Know

• Biogen was co-founded by scientists including Nobel laureates Walter Gilbert and Phillip Sharp.
• The company’s headquarters are in Cambridge’s Kendall Square.
• It is publicly traded and sells medicines around the world.
• This Weston listing is part of the Greater Boston Chamber of Commerce directory.